AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

15.280

-0.330-2.11%

Volume:182.76K

Turnover:2.80M

Market Cap:5.18B

PE:110.99

High:15.510

Open:15.410

Low:15.220

Close:15.610

52wk High:18.220

52wk Low:8.260

Shares:338.72M

Float Shares:275.41M

Volume Ratio:5.79

T/O Rate:0.07%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.138

EPS(LYR):-0.030

ROE:7.36%

ROA:2.71%

PB:7.35

PE(LYR):-501.74

Loading ...

Overview Company News Filings

IBA and Telix Strengthen Ties Through Agreement to Distribute ARTMS QIS

Iba - Iba and Telix Strengthen Ties Through Agreement to Distribute Artms's Qis

THOMSON REUTERS

IBA Agrees to Distribute Telix Unit Artms’ Quantm Solid-Target Cyclotron Technology Worldwide

Jefferies Raises PT on Australia's Telix Pharma After Deal with ITM Isotope Technologies

Telix Wins FDA Fast Track for BiPASS Pre-Biopsy Prostate Cancer Imaging Study

Telix Pharmaceuticals - Illuccix and Gozellix Approved for Pet Imaging of Psma-Positive Prostate Cancer Lesions

THOMSON REUTERS

Telix Pharmaceuticals Limited-FDA Fast Track for Bipass Pre Biopsy Prostate Imaging

THOMSON REUTERS

Australia's Telix Pharmaceuticals to End Week Lower as ITM Deal Weigh

Capmont Sells ITM Stake as Telix Agrees US$ 1.65 Billion Acquisition

Telix Pharma Rises After ITM Deal Selloff; Citi Backs Share Issuance

Telix Pharmaceuticals Receives ASX Waivers on Share Issuance Timing for Acquisition Consideration

MT Newswires Live

Telix Pharmaceuticals Limited-Grant of Waivers of Listing Rule 7.3.4

THOMSON REUTERS

France's Abivax H1 Net Loss Widens on Higher Expenses Driven by Clinical Programs

Deals of the Day-Mergers and Acquisitions

Australian Shares End Flat as Miners Offset Gains in Banks

Australian Shares Flat; Telix Pharmaceuticals to Acquire German Radiopharmaceutical Biotechnology Company for Initial $1.65 Billion Payment

MT Newswires Live

Australia's Telix Falls as Investors Focus on Dilution Risks in ITM Deal

Telix's $50 Mln Synergies Look Good to Bulls

Telix's $2.35b Acquisition Makes Strategic Sense

Telix Pharmaceuticals Announces Shareholder Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/TLX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":15.28,"timestamp":1790899549206,"preClose":15.61,"halted":0,"volume":182756,"delay":0,"changeRate":-0.021140294682895584,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.13769081421281693,"marketStatus":"Trading","change":-0.33,"latestTime":"10-02 10:05:53 AEST","open":15.41,"high":15.51,"low":15.22,"amount":2802690,"amplitude":0.018578,"askPrice":15.29,"askSize":301,"bidPrice":15.27,"bidSize":471,"shortable":3,"etf":0,"ttmEps":0.13769081421281693,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790920800000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":15.61,"openAndCloseTimeList":[[1790899200000,1790920800000]],"volumeRatio":5.792111,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"TLX.AU","preClose":15.61,"auctionPrice":15.41,"auctionVolume":23752,"auctionTime":1790899143702,"referenceTime":1790850603090,"auction":1,"marketStatus":"盘前竞价","timestamp":1790899143702}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.71%","roe":"7.36%","lyrEps":-0.030454,"volumeRatio":5.792111,"shares":338721355,"dividePrice":0,"high":15.51,"amplitude":0.018578,"preClose":15.61,"low":15.22,"week52Low":8.26,"pbRate":"7.35","psRate":"4.03","week52High":18.22,"institutionHeld":0,"latestPrice":15.28,"committee":0.220207,"eps":0.13767292828843392,"divideRate":0,"volume":182756,"delay":0,"ttmEps":0.13767292828843392,"open":15.41,"prevYearClose":11.2,"prevWeekClose":15.9,"prevMonthClose":15.72,"prevQuarterClose":15.72,"fiveDayClose":15.9,"twentyDayClose":16.47,"sixtyDayClose":16.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787184000000,"name":null,"time":"","dateTimestamp":1787148000000,"actualEps":null},{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672346817","title":"IBA and Telix Strengthen Ties Through Agreement to Distribute ARTMS QIS","url":"https://stock-news.laohu8.com/highlight/detail?id=2672346817","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672346817?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:05","pubTimestamp":1790831106,"startTime":"0","endTime":"0","summary":"BRIEF-IBA And Telix Strengthen Ties Through Agreement To Distribute ARTMS QISOct 1 (Reuters)-Ion Beam Applications SAIBAB.BR:IBA AND TELIX STRENGTHEN TIES THROUGH AGREEMENT TO DISTRIBUTE ARTMS'S QISSource text: nGNE87DkPjFurther company coverage:IBAB.BR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45M1B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672343097","title":"Iba - Iba and Telix Strengthen Ties Through Agreement to Distribute Artms's Qis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672343097","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672343097?lang=en_us&edition=fundamental","pubTime":"2026-10-01 13:01","pubTimestamp":1790830861,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45M1B4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672734387","title":"IBA Agrees to Distribute Telix Unit Artms’ Quantm Solid-Target Cyclotron Technology Worldwide","url":"https://stock-news.laohu8.com/highlight/detail?id=2672734387","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672734387?lang=en_us&edition=fundamental","pubTime":"2026-10-01 12:59","pubTimestamp":1790830760,"startTime":"0","endTime":"0","summary":"IBA agrees to distribute Telix unit ARTMS’ QUANTM solid-target cyclotron technology worldwideIBA signed an agreement with ARTMS, a Telix unit, to distribute the QUANTM Irradiation System solid-target ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL2gZcHh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672178482","title":"Jefferies Raises PT on Australia's Telix Pharma After Deal with ITM Isotope Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2672178482","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672178482?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:04","pubTimestamp":1790795080,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies raises PT on Australia's Telix Pharma after deal with ITM Isotope Technologies** Jefferies upgrades price target on Telix PharmaceuticalsTLX.AXto A$32 from A$30** Last week, co said it ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45M1NF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671357228","title":"Telix Wins FDA Fast Track for BiPASS Pre-Biopsy Prostate Cancer Imaging Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2671357228","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671357228?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:31","pubTimestamp":1790721117,"startTime":"0","endTime":"0","summary":"Telix wins FDA Fast Track for BiPASS pre-biopsy prostate cancer imaging studyTelix received FDA Fast Track designation for BiPASS, a Phase 3 program testing 68Ga PSMA-PET with MRI before prostate biop","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL8KhHrF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671288372","title":"Telix Pharmaceuticals - Illuccix and Gozellix Approved for Pet Imaging of Psma-Positive Prostate Cancer Lesions","url":"https://stock-news.laohu8.com/highlight/detail?id=2671288372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671288372?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:21","pubTimestamp":1790720514,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE2DKRGG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671228833","title":"Telix Pharmaceuticals Limited-FDA Fast Track for Bipass Pre Biopsy Prostate Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2671228833","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671228833?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:21","pubTimestamp":1790720514,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE2DKRGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670412960","title":"Australia's Telix Pharmaceuticals to End Week Lower as ITM Deal Weigh","url":"https://stock-news.laohu8.com/highlight/detail?id=2670412960","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670412960?lang=en_us&edition=fundamental","pubTime":"2026-09-25 11:14","pubTimestamp":1790306097,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Telix Pharmaceuticals to end week lower as ITM deal weigh** Shares of Telix PharmaceuticalsTLX.AXup 2.2%; shed 10% for the week so far, on track for its worst week since early Feb, if","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4N45H04U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669930274","title":"Capmont Sells ITM Stake as Telix Agrees US$ 1.65 Billion Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2669930274","media":"Reuters","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669930274?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:22","pubTimestamp":1790256127,"startTime":"0","endTime":"0","summary":"Capmont sells ITM stake as Telix agrees US$ 1.65 billion acquisitionCapmont sold its minority stake in portfolio company ITM Isotope Technologies Munich as part of ITM’s merger with Telix Pharmaceutic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL4NY2qh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669948741","title":"Telix Pharma Rises After ITM Deal Selloff; Citi Backs Share Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2669948741","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669948741?lang=en_us&edition=fundamental","pubTime":"2026-09-22 08:59","pubTimestamp":1790038778,"startTime":"0","endTime":"0","summary":"BUZZ-Telix Pharma rises after ITM deal selloff; Citi backs share issuance** Shares of Telix PharmaceuticalsTLX.AXrise as much as 6.8% to A$16.83, their biggest intraday pct gain since September 15** S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4N45E019:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4585","BK4559","LU1791807156.HKD","LU0162691827.USD","LU2360032135.SGD","BK4534","LU0320765646.SGD","LU2125154935.USD","LU2462157665.USD","LU1201861249.SGD","LU0477156953.USD","LU1668664300.SGD","LU0980610538.SGD","LU0130102774.USD","LU0128525689.USD","LU0170899867.USD","BK7067","LU0203347892.USD","LU1144417596.USD","LU1366192091.USD","LU2236285917.USD","LU1267930227.SGD","LU0648001328.SGD","LU1244550221.USD","IE00BSNM7G36.USD","TLX.AU","LU0203345920.USD","LU2125154778.USD","LU1506573853.SGD","LU2417539215.USD","TFNS","LU0052756011.USD","BK4207","LU0072461881.USD","FTXO","LU0098860793.USD","LU1162221912.USD","BK4588","LU1074936037.SGD","BK4504","LU2456880835.USD","LU0106831901.USD","LU0314106906.USD","LU1244550577.SGD","LU1244550494.USD","LU0310800965.SGD","LU0130517989.USD","IYF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196280","title":"Telix Pharmaceuticals Receives ASX Waivers on Share Issuance Timing for Acquisition Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196280","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669196280?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:25","pubTimestamp":1790033141,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  sought waivers of an ASX rule to allow shares issued as upfront consideration and future consideration to be issued more than three months after its extraordinary general meeting, as the timing is contingent on completion of closing conditions and achievement of specific milestones, according to a Tuesday Australian bourse filing.The company said ASX granted the waivers, with certain conditions, including that shares tied to the upfront payment are issued once the relevant deal conditions are met, and in any case no later than 12 months after shareholders approve the issue.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TLX","TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669195750","title":"Telix Pharmaceuticals Limited-Grant of Waivers of Listing Rule 7.3.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2669195750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669195750?lang=en_us&edition=fundamental","pubTime":"2026-09-22 06:24","pubTimestamp":1790029451,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nTUE5NX0VJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669716198","title":"France's Abivax H1 Net Loss Widens on Higher Expenses Driven by Clinical Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669716198","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669716198?lang=en_us&edition=fundamental","pubTime":"2026-09-22 04:27","pubTimestamp":1790022476,"startTime":"0","endTime":"0","summary":"France's Abivax H1 net loss widens on higher expenses driven by clinical programsOverviewFrance biotechnology firm's H1 2026 net loss widened as operating expenses increasedCompany completed royalty c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL1N45D0VO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669168153","title":"Deals of the Day-Mergers and Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2669168153","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669168153?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:37","pubTimestamp":1789990641,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsSept 21 (Reuters)-The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Monday:** US spirits maker Sazerac launched a takeover o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL6N45D0CA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK1190","BK0084","BK0070","BK7067","600392","BK1513","BK0233","BK0182","TLX.AU","00769"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669531491","title":"Australian Shares End Flat as Miners Offset Gains in Banks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669531491","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669531491?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:25","pubTimestamp":1789975555,"startTime":"0","endTime":"0","summary":"Australian shares end flat as miners offset gains in banksSept 21 (Reuters)-Australian shares ended little changed on Monday as gains in financials offset losses in commodity stocks, while expectation","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AN3PL.AU","LU0788109121.HKD","LU1309081286.SGD","LU1430597077.USD","LU0654597011.USD","LU0955623706.USD","LU0456854461.SGD","LU1046248800.SGD","LU1064927863.SGD","LU0898667661.SGD","BHP.AU","LU0264606111.USD","LU0971552673.USD","BK7508","IE00BWDBJ516.SGD","BK7007","BK7067","CSL.AU","BK7511","COH.AU","LU0011963245.USD","LU0171293334.USD","LU0831103253.SGD","LU1023059493.AUD","TLX.AU","IE00BQJZX424.USD","LU0075056555.USD","LU0345781412.USD","RIO.AU","LU1078025761.USD","LU0330918003.SGD","LU1481599808.USD","SG9999001143.SGD","LU1130305938.SGD","LU1302929846.USD","SG9999002521.SGD","LU0955669360.SGD","LU0955648018.USD","LU0612318971.USD","LU0572939691.SGD","LU0266512473.USD","CBA.AU","LU0345777659.USD","BK5111","LU0345777147.USD","LU1481600234.SGD","LU1487256676.USD","RIO.UK","ANZ.AU","LU2463526074.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669015836","title":"Australian Shares Flat; Telix Pharmaceuticals to Acquire German Radiopharmaceutical Biotechnology Company for Initial $1.65 Billion Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2669015836","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669015836?lang=en_us&edition=fundamental","pubTime":"2026-09-21 14:37","pubTimestamp":1789972642,"startTime":"0","endTime":"0","summary":"Australian shares were flat on Monday, as oil prices eased despite heightened tensions in the Middle East.The S&P/ASX 200 Index was little changed to close at 8,731.90.Brent crude oil futures fell to ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX","BK7104","PPT.AU","BK7062","IOZ.AU","BK4139","BK7506","LU0757428866.USD","OZR.AU","OZF.AU","IIGF.AU","IISV.AU","ZYAU.AU","RMS.AU","GEAR.AU","BEAR.AU","GIVE.AU","LU1303367103.USD","SLF.AU","STW.AU","VAP.AU","XKO.AU","QFN.AU","E200.AU","DACE.AU","BK7067","RBA","LU2098885051.SGD","BBOZ.AU","IMLC.AU","TLX.AU","EIGA.AU","XJO.AU","QRE.AU","BK4137","XAO.AU","VAS.AU","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669372541","title":"Australia's Telix Falls as Investors Focus on Dilution Risks in ITM Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669372541","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669372541?lang=en_us&edition=fundamental","pubTime":"2026-09-21 13:49","pubTimestamp":1789969757,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Telix falls as investors focus on dilution risks in ITM deal** Shares of Telix PharmaceuticalsTLX.AXfall as much as 10.2% to A$16.030, logging their biggest intraday pct fall since Au","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0AZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669344501","title":"Telix's $50 Mln Synergies Look Good to Bulls","url":"https://stock-news.laohu8.com/highlight/detail?id=2669344501","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669344501?lang=en_us&edition=fundamental","pubTime":"2026-09-21 11:54","pubTimestamp":1789962840,"startTime":"0","endTime":"0","summary":"0354 GMT - The potential for US$50 million in cost synergies jumps out at UBS analysts as a key attraction of Telix Pharmaceuticals' US$2.35 billion acquisition of isotope manufacturer ITM. The analysts, who have a last-published buy rating on Telix's Australia-listed stock, tell clients in a note that the vertical integration of Telix with a supplier of key therapeutic isotopes strengthens its platform. They point out that ITM sits within a commercially validated category, with global annual sales of US$800 million for approved somatostatin receptor-targeted radioligand therapies. UBS has a target price of 22.00 Australian dollars on the stock, which is down 5.4% at A$16.88.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669134381","title":"Telix's $2.35b Acquisition Makes Strategic Sense","url":"https://stock-news.laohu8.com/highlight/detail?id=2669134381","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669134381?lang=en_us&edition=fundamental","pubTime":"2026-09-21 11:34","pubTimestamp":1789961640,"startTime":"0","endTime":"0","summary":"0334 GMT - Telix Pharmaceuticals' US$2.35 billion acquisition of ITM gives the Australian company unparalleled exposure to the supply chain for cancer treatments' dominant therapeutic isotope, Bell Potter analyst John Hester says. Hester highlights to clients in a note ITM's position as a leading manufacturer of isotopes including 177Lu, which he points out is used in treatments including Novartis's Pluvicto. With margins on ITM's isotope production well in advance of TLX's margins on its manufacturing, his initial view is that the acquisition makes a lot of strategic sense. Bell Potter is reviewing its forecasts for Telix and its target price on the stock. Shares are down 5.1% at 16.94 Australian dollars.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Telix's $2.35b Acquisition Makes Strategic Sense","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669136711","title":"Telix Pharmaceuticals Announces Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2669136711","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669136711?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:56","pubTimestamp":1789955791,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals announces shareholder meetingTelix Pharmaceuticals will hold an extraordinary general meeting in November 2026.Shareholders will vote on the proposed merger to acquire ITM Isotop","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDLbGJGlX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":199,"code":"91000000","status":"200"}]}}